2m 2m 2m 2m 2m 2m 2m
Amphastar Pharma (AMPH)
NASDAQ
$29.00+$0.40 (+1.40%)
Price as of Nov 12, 2026 8:33 AM EST- $1.2BMarket Cap
- 2.77%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Amphastar Pharma (AMPH)
$29.00+$0.40 (+1.40%)
AMPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.60 | ||
Change | -$0.46 (-1.58%) | ||
Open | $28.87 | ||
High | $29.30 | ||
Low | $28.50 | ||
Previous Close | $29.06 | ||
Volume | 497,666 | ||
30-Day Average Volume | 448,913 | ||
1-Week Change | 2.07% | ||
1-Month Change | 7.44% | ||
1-Year Change | 2.77% | ||
3-Year Change | -45.59% | ||
5-Year Change | 35.03% | ||
Fundamentals | |||
Shares Outstanding | 42.6M | ||
Total Assets | $1.7B | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | $37.8M | ||
Free Cash Flow | $33.4M | ||
EBIT | $51.3M | ||
EBITDA | $58.7M | ||
Net Working Capital | $421.3M | ||
EPS | $0.87 | ||
Enterprise Value/EBITDA | 28 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | 33 | ||
PEG | 1 | ||
Price/Free Cash Flow | 37 | ||
Price/Operating Cash Flow | 28 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue